Thrombotech Ltd.
Records under this name other than patents Thrombotech Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Thrombotech Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,507,436 | Peptides derived from plasminogen activator inhibitor-1 and uses thereof Formerly held Lapsed on the fee record Ended Aug 13, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2021 | From the USPTO record |
| US 7,271,143 | Peptides for regulation of urokinase (uPA) and tissue type (tPA) plasminogen activator and method of optimizing therapeutic efficacy Formerly held Lapsed on the fee record Ended Sep 18, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2019 | From the USPTO record |
| US 6,759,042 | Use of cross-linked, covalently bound urokinase plasminogen activator (scuPA)-urokinase plasminogen activator receptor (suPAR) complex as a fibrinolytic agent Lapsed on the fee record Ended Jul 6, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 6, 2012 | From the USPTO record |
| US 6,911,316 | Medical uses of scuPA/suPAR complex Lapsed on the fee record Ended Jun 28, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jun 28, 2009 | From the USPTO record |